Mid-Day Market Update: NxStage Medical Surges Following Acquisition News; Gemphire Therapeutics Shares Drop
Meanwhile the German DAX declined 0.42 percent, and the French CAC 40 dropped 0.02 percent while U.K. shares rose 0.21 percent. Shares of Gemphire Therapeutics Inc (NASDAQ: GEMP ) were down 50 percent to $9.34 after the company reported top-line data from ROYAL-1 Phase 2b trial. Leading the sector was strength from Sinopec Shanghai Petrochemical Co. (ADR) (NYSE: SHI ) and Companhia Siderurgica Nacional (ADR) (NYSE: SID ). Shares of NxStage Medical, Inc. (NASDAQ: NXTM ) got a boost, shooting up 28 percent to $29.69. In trading on Monday, energy shares were relative laggards, down on the day by about 0.58 percent.
Tyson Foods and NxStage Medical climb; Geo Group skids
NxStage Medical Inc., up $6.53 to $29.67Fresenius Medical Care agreed to buy the medical device company for $30 a share, or just under $2 billion. Geo Group Inc., down $2.04 to $26.02The private prison operator posted weak revenue in the second quarter and its forecast disappointed Wall Street. Armstrong Flooring Inc., down $3.03 to $14.25The flooring company cut its forecasts after it said sales of sheet and wood flooring were weak in the second quarter. Alibaba Group Holding Ltd., up $5.51 to $158.84Alibaba and hotel company Marriott International started a joint venture aimed at Chinese tourists. Rockwell Collins Inc., up $8.07 to $127.07Reuters reported that United Technologies made an offer to buy the aviation electronics maker.collected by :Lucy William
No comments:
Post a Comment